Pediatrics provides specialized medical care for infants, children, and adolescents. Learn about routine screenings, vaccinations, and treatments.
Send us all your questions or requests, and our expert team will assist you.
The clinical presentation of Kawasaki disease is dynamic and evolves through three distinct phases: acute, subacute, and convalescent. Each phase is characterized by a unique set of symptoms and physiological conditions that reflect the underlying progression of the vasculitis. The acute phase is dominated by systemic inflammation and fever; the subacute phase is marked by the resolution of fever and the highest risk of coronary artery aneurysm formation, as well as thrombocytosis; and the gradual normalization of inflammatory markers defines the convalescent phase. Recognizing the nuances of these symptoms is critical because “incomplete” or “atypical” presentations are common, particularly in infants, who are at the highest risk for cardiac damage. At Liv Hospital, the clinical team is trained to identify these subtle patterns to ensure no child is left untreated.
The cardinal symptom of the acute phase is a high-grade, remittent fever that typically exceeds 39°C and often reaches 40°C. Unlike the fever associated with common viral illnesses, which usually responds to antipyretics and resolves within a few days, the fever of Kawasaki disease is notoriously persistent. Without appropriate treatment, it can last for 1 to 2 weeks, and in some cases, up to 3 or 4 weeks. This fever is not merely a symptom but a direct manifestation of the cytokine storm raging within the vasculature. The child is often profoundly irritable, inconsolable, and lethargic, reflecting the severity of the systemic inflammation. This extreme irritability is often a disproportionate clinical sign that alerts experienced pediatricians to the possibility of Kawasaki disease over more benign conditions.
The changes in the mucous membranes are among the most distinctive diagnostic features. The lips typically become deeply erythematous, dry, fissured, and may peel or bleed spontaneously. The oral mucosa becomes inflamed, and the tongue develops a characteristic appearance known as “strawberry tongue.” This condition is caused by the sloughing of the filiform papillae (the coating of the tongue) and the engorgement of the fungiform papillae, creating a bright red, bumpy surface resembling a strawberry. Unlike streptococcal pharyngitis, there is usually no exudate (pus) on the tonsils, although the throat may be diffusely red. These oral symptoms can make feeding painful, leading to reduced oral intake and requiring careful nutritional support.
Changes in the peripheral extremities occur in a biphasic pattern. In the acute phase, the hands and feet develop a hard, non-pitting edema (swelling). The palms and soles become diffusely erythematous, often appearing a deep, angry red. This swelling can be painful, causing the child to refuse to walk or hold objects. As the disease progresses to the subacute phase (typically 2 to 3 weeks after onset), a characteristic periungual desquamation (peeling) occurs. This peeling usually starts at the junction of the nail and the skin on the fingers and toes and can extend to involve large sheets of skin shedding from the palms and soles. This desquamation is a retrospective sign of the intense microvasculitis that occurred in the acute phase and is often the sign that confirms the diagnosis in retrospective cases.
The rash of Kawasaki disease is termed “polymorphous” because it can take many different forms, confusing the diagnostic picture. It can present as a diffuse maculopapular rash (flat and raised red spots), a scarlatiniform rash (like sandpaper), or erythema multiforme-like lesions (target-like circles). It is typically widespread, involving the trunk and extremities, and is often accentuated in the perineal region, where early desquamation may occur. A specific, highly suggestive sign seen in countries with BCG vaccination programs is redness and induration (hardening) at the site of a previous BCG scar. This phenomenon, known as BCG reactivation, results from cross-reactivity between the immune response to Kawasaki disease and mycobacterial heat shock proteins, making it a valuable early clinical clue.
Bilateral non-exudative conjunctival injection is present in the vast majority of cases. This involves the bulbar conjunctiva (the white part of the eye) becoming deeply red due to vascular dilation. Crucially, the limbal area (the zone immediately surrounding the iris) is often spared, creating a halo effect. There is typically no discharge, distinguishing it from bacterial conjunctivitis. Anterior uveitis (inflammation inside the front of the eye) may also be present, visible only with slit-lamp examination. Cervical lymphadenopathy is the least consistent feature but is defined as a unilateral node larger than 1.5 cm. This lymph node is typically firm, non-fluctuant, and not warm to the touch, distinguishing it from bacterial lymphadenitis.
A distinct and severe subgroup of patients presents with Kawasaki Disease Shock Syndrome. These children exhibit signs of hemodynamic instability, including hypotension (low blood pressure) and poor perfusion, mimicking septic shock or toxic shock syndrome. This condition is driven by a massive cytokine storm leading to significant vascular leakage and myocardial dysfunction. Recognizing this syndrome is vital because these patients are at a significantly higher risk for coronary artery abnormalities and IVIG resistance. They require aggressive fluid resuscitation and often inotropic support in an intensive care setting, distinguishing their care pathway from standard Kawasaki disease management.
Send us all your questions or requests, and our expert team will assist you.
The fever is typically higher, lasts much longer (more than 5 days), and does not respond well to standard fever-reducing medications or antibiotics.
The rash can be uncomfortable and sometimes itchy, but the primary source of pain is usually the swelling in the hands and feet or the sore mouth.
Immune system activation in Kawasaki disease specifically targets proteins also found in the BCG vaccine scar, causing the scar to become inflamed again.
Many survivors can have children, but fertility can be affected by chemotherapy and radiation. The risk depends on the specific drugs, doses, and radiation location used. Fertility preservation methods (like sperm or egg banking) and regular checks of hormone levels help manage reproductive health.
Acute symptoms are the “active” signs, such as fever and rash, while subacute symptoms occur later, such as skin peeling and changes in the platelet count.
Treatments involving the brain (like radiation or intrathecal chemotherapy) or extended absences from school can affect processing speed, attention, and memory. This is often called “cognitive late effects.” Neuropsychological testing helps identify these issues so schools can provide necessary accommodations, such as extra time on tests.
Certain chemotherapy drugs, specifically anthracyclines (like doxorubicin), can weaken the heart muscle. This damage might not show up immediately, but it can lead to heart failure years later. Regular echocardiograms are necessary to monitor heart function and catch any decline early so it can be managed.
Many survivors can have children, but fertility can be affected by chemotherapy and radiation. The risk depends on the specific drugs, doses, and radiation location used. Fertility preservation methods (like sperm or egg banking) and regular checks of hormone levels help manage reproductive health.
A Survivorship Care Plan is a personalized document given to patients after treatment ends. It details the exact diagnosis, the treatments received (total drug doses and radiation fields), and a schedule for future check-ups and screening tests to monitor for late effects. It is a roadmap for long-term health.
While the eyes look very red and scary, the inflammation is usually superficial and resolves without causing long-term damage to the child’s vision.
Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.
Your Comparison List (you must select at least 2 packages)
